LY2119620
CAS No. 886047-22-9
LY2119620 ( LY2119620; LY 2119620; LY-2119620 )
Catalog No. M17642 CAS No. 886047-22-9
LY2119620 is a specific, and allosteric agonist of human M2 and M4 muscarinic acetylcholine receptors.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 66 | In Stock |
|
5MG | 113 | In Stock |
|
10MG | 178 | In Stock |
|
25MG | 344 | In Stock |
|
50MG | 512 | In Stock |
|
100MG | 737 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY2119620
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2119620 is a specific, and allosteric agonist of human M2 and M4 muscarinic acetylcholine receptors.
-
DescriptionLY2119620 is a positive allosteric modulator of the M2 and M4 muscarinic acetylcholine receptors (mAChRs).
-
SynonymsLY2119620; LY 2119620; LY-2119620
-
PathwayOthers
-
TargetOther Targets
-
RecptorM2 mAChR;M4 mAChR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number886047-22-9
-
Formula Weight437.94
-
Molecular FormulaC19H24ClN5O3S
-
Purity98%
-
SolubilityDMSO : 67.5 mg/mL. 154.13 mM; H2O : < 0.1 mg/mL
-
SMILESCN1CCN(CC1)C(=O)COc1nc2sc(C(=O)NC3CC3)c(N)c2c(C)c1Cl
-
Chemical Name3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methyl-1-piperazinyl)-2-oxoethoxy]-thieno[2,3-b]pyridine-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Croy C H, Schober D A, Xiao H, et al. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.[J]. Molecular Pharmacology, 2014, 86(1):106-115.
molnova catalog
related products
-
P300/CBP-IN-3
P300/CBP-IN-3 is an inhibitor of p300/CBP histone acetyltransferase.
-
6-ROX
6-ROX is a fluorescent oligonucleotide marker and acts as an acceptor molecule coupled to 5-FAM as the donor in FRET imaging with excitation of 568nm and emission of 568nm.
-
Gracillin
Gracillin can induce cell cycle arrest, oxidative stress, and apoptosis in HL60 cells, and has the potential to be developed as an antitumor agent.